During Friday’s trading session, shares of a company manufacturing photovoltaic modules and providing all-inclusive solar energy solutions are in focus on NSE, after securing a commercial order worth Rs. Rs. 378 crores for the supply of solar modules.

With a market capitalisation of Rs. 1,841.6 crores, at 10:42 a.m., the shares of Alpex Solar Limited were trading in the red at Rs. 752.5 on NSE, down by nearly 3 percent, as against its previous closing price of Rs. 774.65.

What’s the News

According to the latest regulatory filings on the NSE, Alpex Solar Limited has secured a commercial order worth Rs. 378 crores from a Leading Industry Player for the supply of solar modules. The order is scheduled to be completed by March 2026.

Previous Updates

23rd April: Alpex Solar bagged an order for the supply of Solar Modules amounting to Rs. 380.52 crores from a leading manufacturer for the supply of solar modules.

25th April: The company received an order worth Rs. 65.33 crores from Haryana Renewable Energy Development Agency (HAREDA) under Component-B of the PM-KUSUM Scheme for the supply of 2,119 solar water pumps.

Financial Performance

Alpex Solar reported a significant growth in its revenue from operations, showing a year-on-year rise of around 137 percent from Rs. 79 crores in Q4 FY24 to Rs. 188 crores in Q4 FY25.

Similarly, its net profit increased during the same period from Rs. 5 crores to Rs. 24 crores, representing an impressive growth of around 380 percent YoY.

About the Company

Incorporated in 1993, Alpex Solar Limited is primarily engaged in the business of manufacturing of solar modules and assembling of solar pumps in India.

Written by Shivani Singh

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

×